Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GBS Ventures

Founders Brigitte Smith Geoff Brooke

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 64
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 30
Rounds per year 2.37
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.53
Exits 11
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Medical
  • Pharmaceutical
Summary

GBS Ventures appeared to be the VC, which was created in 1996. The company was established in Australia. The main department of described VC is located in the Melbourne.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the GBS Ventures, startups are often financed by Sofinnova Investments, QIC BioVentures, Prolog Ventures. The meaningful sponsors for the fund in investment in the same round are Uniseed Ventures, Delphi Ventures, Alloy Ventures. In the next rounds fund is usually obtained by Vivo Capital, Uniseed Ventures, Sofinnova Investments.

The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Nuon Therapeutics, NovaSys, CHF Solutions, Inc.. Among the most successful fund investment fields, there are Medical Device, Medical.

Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The average startup value when the investment from GBS Ventures is 50-100 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this GBS Ventures works on 11 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2017. The important activity for fund was in 2010.

This organization was formed by Brigitte Smith, Geoff Brooke. We also calculated 2 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GBS Ventures:
Typical Co-investors
GBS Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GBS Ventures:

Funds with similar focus

Funds from Australia
Funds with similar focus located in Australia:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Moximed

Biotechnology
Health Care
Medical Device
$40M16 Aug 2022 Hayward, California, United States

Moximed

Biotechnology
Health Care
Medical Device
$50M17 Mar 2017 Hayward, California, United States

Moximed

Biotechnology
Health Care
Medical Device
$50M16 Mar 2017 Hayward, California, United States

Moximed

Biotechnology
Health Care
Medical Device
$12M27 Jan 2016 Hayward, California, United States

Elastagen

Clinical Trials
Medical
Medical Device
$9M07 Jan 2016 Sydney, New South Wales, Australia

Moximed

Biotechnology
Health Care
Medical Device
$33M07 May 2015 Hayward, California, United States

Health Care
Health Diagnostics
Medical Device
$25M23 Sep 2014 Irvine, California, United States

Biotechnology
Health Care
Pharmaceutical
$45M10 Apr 2014 England

Neurovance

Biotechnology
Clinical Trials
Neuroscience
$6M03 Apr 2014 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GBS Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 64
Average round size 16M
Rounds per year 2.37
Peak activity year 2010
Lead investments 10
Follow on index 0.53
Exits 11
Group Appearance index 0.91

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Moximed

Biotechnology
Health Care
Medical Device
$40M16 Aug 2022 Hayward, California, United States

Moximed

Biotechnology
Health Care
Medical Device
$50M17 Mar 2017 Hayward, California, United States

Moximed

Biotechnology
Health Care
Medical Device
$50M16 Mar 2017 Hayward, California, United States

Moximed

Biotechnology
Health Care
Medical Device
$12M27 Jan 2016 Hayward, California, United States

Elastagen

Clinical Trials
Medical
Medical Device
$9M07 Jan 2016 Sydney, New South Wales, Australia

Moximed

Biotechnology
Health Care
Medical Device
$33M07 May 2015 Hayward, California, United States

Health Care
Health Diagnostics
Medical Device
$25M23 Sep 2014 Irvine, California, United States

Biotechnology
Health Care
Pharmaceutical
$45M10 Apr 2014 England

Neurovance

Biotechnology
Clinical Trials
Neuroscience
$6M03 Apr 2014 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: